US Patent Issued to Ablynx, Sanofi on May 19 for "Techniques for predicting, detecting and reducing a specific protein interference in assays involving immunoglobulin single variable domains" (Belgian, German Inventors)

Posted On: 2026-05-19

ALEXANDRIA, Va., May 19 -- United States Patent no. 12,630,609, issued on May 19, was assigned to Ablynx NV (Ghent-Zwijnaarde, Belgium) and Sanofi (Paris).

"Techniques for predicting, detecting and reducing a specific protein interference in assays involving immunoglobulin single variable domains" was invented by Judith Baumeister (Mechelen, Belgium), Marie-Paule Lucienne Armanda Bouche (Gentbrugge, Belgium), Carlo Boutton (Wielsbeke, Belgium), Marie-Ange Buyse (Merelbeke, Belgium), Veerle Snoeck (Zingem, Belgium), Stephanie Staelens (Wevelgem, Belgium), Bruno Dombrecht (Heusden, Belgium), Peter Schotte (De Pinte, Belgium), Cedric Jozef Neotere Ververken (Merelbeke, Belgium), Gerald Beste (Ghent, Belgium), Guy Hermans (Merelbeke, Belgium),...

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

US Patent Issued to Ablynx, Sanofi on May 19 for "Techniques for predicting, detecting and reducing a specific protein interference in assays involving immunoglobulin single variable domains" (Belgian, German Inventors)